NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) Stock Competitors & Peer Comparison
See NHIV's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Financial - Conglomerates Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for NHIV and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| NHIV | $9.94 | -0.65% | 273.5M | N/A | N/A | N/A |
| FRHC | $165.47 | -5.23% | 10.6B | 65.92 | $2.51 | N/A |
| RILYK | $25.23 | +0.16% | 787.6M | N/A | N/A | N/A |
| RILYM | $25.11 | +0.00% | 753M | N/A | N/A | N/A |
| DMII | $10.23 | -0.00% | 652M | 73.11 | $0.14 | N/A |
| DMIIU | $10.25 | -0.10% | 650.7M | 50.34 | $0.20 | N/A |
| RILYO | $25.13 | -0.02% | 573.5M | N/A | N/A | N/A |
| VACHU | $14.50 | +0.00% | 475.5M | N/A | N/A | N/A |
| LEGT-UN | $18.00 | +0.90% | 467.4M | N/A | N/A | N/A |
| TMS | $5.73 | +11.70% | 424M | N/A | N/A | N/A |
Stock Comparison
Freedom Holding Corp. (NASDAQ: FRHC)
NHIV vs FRHC Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, FRHC has a market cap of 10.6B. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while FRHC trades at $165.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas FRHC's P/E ratio is 65.92. In terms of profitability, NHIV's ROE is N/A, compared to FRHC's ROE of +0.11%. Regarding short-term risk, NHIV is less volatile compared to FRHC. This indicates lower risk in terms of short-term price fluctuations for NHIV.Check FRHC's competition here
B. Riley Financial, Inc. 5.50% Senior Notes Due 2026 (NASDAQ: RILYK)
NHIV vs RILYK Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, RILYK has a market cap of 787.6M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while RILYK trades at $25.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas RILYK's P/E ratio is N/A. In terms of profitability, NHIV's ROE is N/A, compared to RILYK's ROE of +94.15%. Regarding short-term risk, NHIV is less volatile compared to RILYK. This indicates lower risk in terms of short-term price fluctuations for NHIV.Check RILYK's competition here
B. Riley Financial, Inc. - 6.37 (NASDAQ: RILYM)
NHIV vs RILYM Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, RILYM has a market cap of 753M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while RILYM trades at $25.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas RILYM's P/E ratio is N/A. In terms of profitability, NHIV's ROE is N/A, compared to RILYM's ROE of +94.15%. Regarding short-term risk, NHIV is less volatile compared to RILYM. This indicates lower risk in terms of short-term price fluctuations for NHIV.Check RILYM's competition here
Drugs Made In America Acquisition II Corp. Ordinary Shares (NASDAQ: DMII)
NHIV vs DMII Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, DMII has a market cap of 652M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while DMII trades at $10.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas DMII's P/E ratio is 73.11. In terms of profitability, NHIV's ROE is N/A, compared to DMII's ROE of +0.03%. Regarding short-term risk, NHIV is less volatile compared to DMII. This indicates lower risk in terms of short-term price fluctuations for NHIV.Check DMII's competition here
Drugs Made In America Acquisition II Corp. Unit (NASDAQ: DMIIU)
NHIV vs DMIIU Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, DMIIU has a market cap of 650.7M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while DMIIU trades at $10.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas DMIIU's P/E ratio is 50.34. In terms of profitability, NHIV's ROE is N/A, compared to DMIIU's ROE of +0.03%. Regarding short-term risk, NHIV is similarly volatile compared to DMIIU. This indicates similar risk in terms of short-term price fluctuations for NHIV.Check DMIIU's competition here
B. Riley Financial, Inc. - 6.75 (NASDAQ: RILYO)
NHIV vs RILYO Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, RILYO has a market cap of 573.5M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while RILYO trades at $25.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas RILYO's P/E ratio is N/A. In terms of profitability, NHIV's ROE is N/A, compared to RILYO's ROE of +94.15%. Regarding short-term risk, NHIV is less volatile compared to RILYO. This indicates lower risk in terms of short-term price fluctuations for NHIV.Check RILYO's competition here
Voyager Acquisition Corp. (NASDAQ: VACHU)
NHIV vs VACHU Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, VACHU has a market cap of 475.5M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while VACHU trades at $14.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas VACHU's P/E ratio is N/A. In terms of profitability, NHIV's ROE is N/A, compared to VACHU's ROE of +0.04%. Regarding short-term risk, NHIV is less volatile compared to VACHU. This indicates lower risk in terms of short-term price fluctuations for NHIV.Check VACHU's competition here
Legato Merger Corp. III (AMEX: LEGT-UN)
NHIV vs LEGT-UN Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, LEGT-UN has a market cap of 467.4M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while LEGT-UN trades at $18.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas LEGT-UN's P/E ratio is N/A. In terms of profitability, NHIV's ROE is N/A, compared to LEGT-UN's ROE of +0.04%. Regarding short-term risk, NHIV is less volatile compared to LEGT-UN. This indicates lower risk in terms of short-term price fluctuations for NHIV.Check LEGT-UN's competition here
Teamshares Inc. (NASDAQ: TMS)
NHIV vs TMS Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, TMS has a market cap of 424M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while TMS trades at $5.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas TMS's P/E ratio is N/A. In terms of profitability, NHIV's ROE is N/A, compared to TMS's ROE of N/A. Regarding short-term risk, NHIV is less volatile compared to TMS. This indicates lower risk in terms of short-term price fluctuations for NHIV.Check TMS's competition here
DeFi Development Corp. (NASDAQ: CHAD)
NHIV vs CHAD Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, CHAD has a market cap of 326.2M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while CHAD trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas CHAD's P/E ratio is -1.52. In terms of profitability, NHIV's ROE is N/A, compared to CHAD's ROE of +0.00%. Regarding short-term risk, NHIV is less volatile compared to CHAD. This indicates lower risk in terms of short-term price fluctuations for NHIV.Check CHAD's competition here
Safeguard Acquisition Corp. (NYSE: SAC)
NHIV vs SAC Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, SAC has a market cap of 317.4M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while SAC trades at $10.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas SAC's P/E ratio is 80.13. In terms of profitability, NHIV's ROE is N/A, compared to SAC's ROE of -0.52%. Regarding short-term risk, NHIV is similarly volatile compared to SAC. This indicates similar risk in terms of short-term price fluctuations for NHIV.Check SAC's competition here
Velos Acquisition I Corp. Units Cons of 1 Sh + 1/2 Red Wt (NASDAQ: VLOSU)
NHIV vs VLOSU Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, VLOSU has a market cap of 310.8M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while VLOSU trades at $10.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas VLOSU's P/E ratio is 95.58. In terms of profitability, NHIV's ROE is N/A, compared to VLOSU's ROE of N/A. Regarding short-term risk, NHIV is similarly volatile compared to VLOSU. This indicates similar risk in terms of short-term price fluctuations for NHIV.Check VLOSU's competition here
Velos Acquisition I Corp. (NASDAQ: VLOS)
NHIV vs VLOS Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, VLOS has a market cap of 309.2M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while VLOS trades at $10.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas VLOS's P/E ratio is 95.09. In terms of profitability, NHIV's ROE is N/A, compared to VLOS's ROE of N/A. Regarding short-term risk, NHIV is less volatile compared to VLOS. This indicates lower risk in terms of short-term price fluctuations for NHIV.Check VLOS's competition here
BRC Group Holdings, Inc. 6.50% Senior Notes Due 2026 (NASDAQ: RILYN)
NHIV vs RILYN Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, RILYN has a market cap of 295.7M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while RILYN trades at $25.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas RILYN's P/E ratio is 2.30. In terms of profitability, NHIV's ROE is N/A, compared to RILYN's ROE of +94.15%. Regarding short-term risk, NHIV is less volatile compared to RILYN. This indicates lower risk in terms of short-term price fluctuations for NHIV.Check RILYN's competition here
Cantor Equity Partners II, Inc. (NASDAQ: CEPT)
NHIV vs CEPT Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, CEPT has a market cap of 289.6M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while CEPT trades at $11.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas CEPT's P/E ratio is -107.09. In terms of profitability, NHIV's ROE is N/A, compared to CEPT's ROE of +0.01%. Regarding short-term risk, NHIV is less volatile compared to CEPT. This indicates lower risk in terms of short-term price fluctuations for NHIV.Check CEPT's competition here
Evernorth Holdings, Inc. Class A (NASDAQ: XRPN)
NHIV vs XRPN Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, XRPN has a market cap of 279.7M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while XRPN trades at $7.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas XRPN's P/E ratio is 81.56. In terms of profitability, NHIV's ROE is N/A, compared to XRPN's ROE of -0.24%. Regarding short-term risk, NHIV is less volatile compared to XRPN. This indicates lower risk in terms of short-term price fluctuations for NHIV.Check XRPN's competition here
Mountain Lake Acquisition Corp. II Class A Ordinary Shares (NASDAQ: MLAA)
NHIV vs MLAA Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, MLAA has a market cap of 261.8M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while MLAA trades at $10.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas MLAA's P/E ratio is N/A. In terms of profitability, NHIV's ROE is N/A, compared to MLAA's ROE of N/A. Regarding short-term risk, NHIV is similarly volatile compared to MLAA. This indicates similar risk in terms of short-term price fluctuations for NHIV.Check MLAA's competition here
Keystone Acquisition Corp. Unit (NASDAQ: KEYYU)
NHIV vs KEYYU Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, KEYYU has a market cap of 254.8M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while KEYYU trades at $10.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas KEYYU's P/E ratio is N/A. In terms of profitability, NHIV's ROE is N/A, compared to KEYYU's ROE of N/A. Regarding short-term risk, NHIV is less volatile compared to KEYYU. This indicates lower risk in terms of short-term price fluctuations for NHIV.Check KEYYU's competition here
OneIM Acquisition Corp. Warrant (NASDAQ: OIMAW)
NHIV vs OIMAW Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, OIMAW has a market cap of 250M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while OIMAW trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas OIMAW's P/E ratio is -437.50. In terms of profitability, NHIV's ROE is N/A, compared to OIMAW's ROE of -0.57%. Regarding short-term risk, NHIV is less volatile compared to OIMAW. This indicates lower risk in terms of short-term price fluctuations for NHIV.Check OIMAW's competition here
Roman DBDR Acquisition Corp. II (NASDAQ: DRDBU)
NHIV vs DRDBU Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, DRDBU has a market cap of 247.9M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while DRDBU trades at $10.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas DRDBU's P/E ratio is 60.27. In terms of profitability, NHIV's ROE is N/A, compared to DRDBU's ROE of +0.02%. Regarding short-term risk, NHIV is less volatile compared to DRDBU. This indicates lower risk in terms of short-term price fluctuations for NHIV.Check DRDBU's competition here
Roman DBDR Acquisition Corp. II (NASDAQ: DRDB)
NHIV vs DRDB Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, DRDB has a market cap of 247.9M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while DRDB trades at $10.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas DRDB's P/E ratio is 60.49. In terms of profitability, NHIV's ROE is N/A, compared to DRDB's ROE of +0.02%. Regarding short-term risk, NHIV is less volatile compared to DRDB. This indicates lower risk in terms of short-term price fluctuations for NHIV.Check DRDB's competition here
Evernorth Holdings Inc. Wt (NASDAQ: XRPNW)
NHIV vs XRPNW Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, XRPNW has a market cap of 244.6M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while XRPNW trades at $1.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas XRPNW's P/E ratio is 11.99. In terms of profitability, NHIV's ROE is N/A, compared to XRPNW's ROE of -0.24%. Regarding short-term risk, NHIV is less volatile compared to XRPNW. This indicates lower risk in terms of short-term price fluctuations for NHIV.Check XRPNW's competition here
Inflection Point Acquisition Corp. VII Units Cons of 1 Shs A + 1/3 Red Wt (NASDAQ: IPXGU)
NHIV vs IPXGU Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, IPXGU has a market cap of 244.5M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while IPXGU trades at $10.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas IPXGU's P/E ratio is N/A. In terms of profitability, NHIV's ROE is N/A, compared to IPXGU's ROE of N/A. Regarding short-term risk, NHIV is less volatile compared to IPXGU. This indicates lower risk in terms of short-term price fluctuations for NHIV.Check IPXGU's competition here
Inflection Point Acquisition Corp. VII (NASDAQ: IPXG)
NHIV vs IPXG Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, IPXG has a market cap of 242M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while IPXG trades at $10.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas IPXG's P/E ratio is N/A. In terms of profitability, NHIV's ROE is N/A, compared to IPXG's ROE of N/A. Regarding short-term risk, NHIV is less volatile compared to IPXG. This indicates lower risk in terms of short-term price fluctuations for NHIV.Check IPXG's competition here
Illumination Acquisition Corp I Class A Ordinary Shares (NASDAQ: ILLU)
NHIV vs ILLU Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, ILLU has a market cap of 236.5M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while ILLU trades at $10.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas ILLU's P/E ratio is N/A. In terms of profitability, NHIV's ROE is N/A, compared to ILLU's ROE of +0.05%. Regarding short-term risk, NHIV is less volatile compared to ILLU. This indicates lower risk in terms of short-term price fluctuations for NHIV.Check ILLU's competition here
Illumination Acquisition Corp I (NASDAQ: ILLUU)
NHIV vs ILLUU Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, ILLUU has a market cap of 236.4M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while ILLUU trades at $10.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas ILLUU's P/E ratio is N/A. In terms of profitability, NHIV's ROE is N/A, compared to ILLUU's ROE of +0.05%. Regarding short-term risk, NHIV is similarly volatile compared to ILLUU. This indicates similar risk in terms of short-term price fluctuations for NHIV.Check ILLUU's competition here
Bluerock Acquisition Corp. Class A Ordinary Shares (NASDAQ: BLRK)
NHIV vs BLRK Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, BLRK has a market cap of 233M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while BLRK trades at $10.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas BLRK's P/E ratio is 85.77. In terms of profitability, NHIV's ROE is N/A, compared to BLRK's ROE of N/A. Regarding short-term risk, NHIV is less volatile compared to BLRK. This indicates lower risk in terms of short-term price fluctuations for NHIV.Check BLRK's competition here
Viking Acquisition Corp. II (NYSE: VII)
NHIV vs VII Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, VII has a market cap of 232.4M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while VII trades at $9.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas VII's P/E ratio is N/A. In terms of profitability, NHIV's ROE is N/A, compared to VII's ROE of +0.00%. Regarding short-term risk, NHIV is less volatile compared to VII. This indicates lower risk in terms of short-term price fluctuations for NHIV.Check VII's competition here
TRG Latin America Acquisitions Corp. (NASDAQ: TRGSU)
NHIV vs TRGSU Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, TRGSU has a market cap of 215M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while TRGSU trades at $10.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas TRGSU's P/E ratio is N/A. In terms of profitability, NHIV's ROE is N/A, compared to TRGSU's ROE of N/A. Regarding short-term risk, NHIV is less volatile compared to TRGSU. This indicates lower risk in terms of short-term price fluctuations for NHIV.Check TRGSU's competition here
Legato Merger Corp. III (AMEX: LEGT)
NHIV vs LEGT Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, LEGT has a market cap of 214.8M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while LEGT trades at $9.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas LEGT's P/E ratio is 32.83. In terms of profitability, NHIV's ROE is N/A, compared to LEGT's ROE of +0.04%. Regarding short-term risk, NHIV is less volatile compared to LEGT. This indicates lower risk in terms of short-term price fluctuations for NHIV.Check LEGT's competition here
NewHold Investment Corp IV (NASDAQ: NHIVU)
NHIV vs NHIVU Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, NHIVU has a market cap of 214.3M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while NHIVU trades at $10.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas NHIVU's P/E ratio is N/A. In terms of profitability, NHIV's ROE is N/A, compared to NHIVU's ROE of N/A. Regarding short-term risk, NHIV is similarly volatile compared to NHIVU. This indicates similar risk in terms of short-term price fluctuations for NHIV.Check NHIVU's competition here
Quantum Leap Acquisition Corp (NYSE: QLEP)
NHIV vs QLEP Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, QLEP has a market cap of 212.3M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while QLEP trades at $10.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas QLEP's P/E ratio is N/A. In terms of profitability, NHIV's ROE is N/A, compared to QLEP's ROE of N/A. Regarding short-term risk, NHIV is less volatile compared to QLEP. This indicates lower risk in terms of short-term price fluctuations for NHIV.Check QLEP's competition here
Jones Ventures INTL Acquisition1 Corp (NASDAQ: JONEU)
NHIV vs JONEU Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, JONEU has a market cap of 209.8M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while JONEU trades at $9.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas JONEU's P/E ratio is N/A. In terms of profitability, NHIV's ROE is N/A, compared to JONEU's ROE of +7.88%. Regarding short-term risk, NHIV is similarly volatile compared to JONEU. This indicates similar risk in terms of short-term price fluctuations for NHIV.Check JONEU's competition here
TRG Latin America Acquisitions Corp. Class A Ordinary Shares (NASDAQ: TRGS)
NHIV vs TRGS Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, TRGS has a market cap of 208.4M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while TRGS trades at $9.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas TRGS's P/E ratio is N/A. In terms of profitability, NHIV's ROE is N/A, compared to TRGS's ROE of N/A. Regarding short-term risk, NHIV is similarly volatile compared to TRGS. This indicates similar risk in terms of short-term price fluctuations for NHIV.Check TRGS's competition here
Safeguard Acquisition Corp. (NYSE: SAC-UN)
NHIV vs SAC-UN Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, SAC-UN has a market cap of 208M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while SAC-UN trades at $10.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas SAC-UN's P/E ratio is 981.13. In terms of profitability, NHIV's ROE is N/A, compared to SAC-UN's ROE of -0.52%. Regarding short-term risk, NHIV is similarly volatile compared to SAC-UN. This indicates similar risk in terms of short-term price fluctuations for NHIV.Check SAC-UN's competition here
Vendome Acquisition Corporation I Warrant (NASDAQ: VNMEW)
NHIV vs VNMEW Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, VNMEW has a market cap of 207.6M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while VNMEW trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas VNMEW's P/E ratio is 0.71. In terms of profitability, NHIV's ROE is N/A, compared to VNMEW's ROE of +9.36%. Regarding short-term risk, NHIV is less volatile compared to VNMEW. This indicates lower risk in terms of short-term price fluctuations for NHIV.Check VNMEW's competition here
Vendome Acquisition Corporation I (NASDAQ: VNME)
NHIV vs VNME Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, VNME has a market cap of 207.6M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while VNME trades at $10.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas VNME's P/E ratio is 36.77. In terms of profitability, NHIV's ROE is N/A, compared to VNME's ROE of +9.36%. Regarding short-term risk, NHIV is less volatile compared to VNME. This indicates lower risk in terms of short-term price fluctuations for NHIV.Check VNME's competition here
Jones Ventures Intl Acquisition1 (NASDAQ: JONE)
NHIV vs JONE Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, JONE has a market cap of 207.4M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while JONE trades at $9.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas JONE's P/E ratio is N/A. In terms of profitability, NHIV's ROE is N/A, compared to JONE's ROE of +7.88%. Regarding short-term risk, NHIV is less volatile compared to JONE. This indicates lower risk in terms of short-term price fluctuations for NHIV.Check JONE's competition here
Vendome Acquisition Corporation I Unit (NASDAQ: VNMEU)
NHIV vs VNMEU Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, VNMEU has a market cap of 206M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while VNMEU trades at $10.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas VNMEU's P/E ratio is 66.54. In terms of profitability, NHIV's ROE is N/A, compared to VNMEU's ROE of +9.36%. Regarding short-term risk, NHIV is similarly volatile compared to VNMEU. This indicates similar risk in terms of short-term price fluctuations for NHIV.Check VNMEU's competition here
Interprivate Investment Partners V Inc. (NASDAQ: IPVV)
NHIV vs IPVV Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, IPVV has a market cap of 204.6M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while IPVV trades at $9.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas IPVV's P/E ratio is N/A. In terms of profitability, NHIV's ROE is N/A, compared to IPVV's ROE of N/A. Regarding short-term risk, NHIV is less volatile compared to IPVV. This indicates lower risk in terms of short-term price fluctuations for NHIV.Check IPVV's competition here
Xterax Corporation II (NASDAQ: XTERU)
NHIV vs XTERU Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, XTERU has a market cap of 204.2M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while XTERU trades at $9.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas XTERU's P/E ratio is N/A. In terms of profitability, NHIV's ROE is N/A, compared to XTERU's ROE of N/A. Regarding short-term risk, NHIV is similarly volatile compared to XTERU. This indicates similar risk in terms of short-term price fluctuations for NHIV.Check XTERU's competition here
QDRO Acquisition Corp. Units (NASDAQ: QADRU)
NHIV vs QADRU Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, QADRU has a market cap of 203M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while QADRU trades at $10.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas QADRU's P/E ratio is N/A. In terms of profitability, NHIV's ROE is N/A, compared to QADRU's ROE of N/A. Regarding short-term risk, NHIV is less volatile compared to QADRU. This indicates lower risk in terms of short-term price fluctuations for NHIV.Check QADRU's competition here
QDRO Acquisition Corp. Class A Ordinary Shares (NASDAQ: QADR)
NHIV vs QADR Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, QADR has a market cap of 202.6M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while QADR trades at $10.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas QADR's P/E ratio is 296.20. In terms of profitability, NHIV's ROE is N/A, compared to QADR's ROE of N/A. Regarding short-term risk, NHIV is less volatile compared to QADR. This indicates lower risk in terms of short-term price fluctuations for NHIV.Check QADR's competition here
Xterax Corporation II (NASDAQ: XTER)
NHIV vs XTER Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, XTER has a market cap of 202.4M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while XTER trades at $9.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas XTER's P/E ratio is N/A. In terms of profitability, NHIV's ROE is N/A, compared to XTER's ROE of N/A. Regarding short-term risk, NHIV is less volatile compared to XTER. This indicates lower risk in terms of short-term price fluctuations for NHIV.Check XTER's competition here
Meridian3 Ind S Acquisition Corp. (NASDAQ: MIAC)
NHIV vs MIAC Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, MIAC has a market cap of 199.8M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while MIAC trades at $9.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas MIAC's P/E ratio is N/A. In terms of profitability, NHIV's ROE is N/A, compared to MIAC's ROE of N/A. Regarding short-term risk, NHIV is less volatile compared to MIAC. This indicates lower risk in terms of short-term price fluctuations for NHIV.Check MIAC's competition here
Breeze Acquisition Corp. II (NASDAQ: BREZ)
NHIV vs BREZ Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, BREZ has a market cap of 199.2M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while BREZ trades at $10.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas BREZ's P/E ratio is 1654.10. In terms of profitability, NHIV's ROE is N/A, compared to BREZ's ROE of +0.53%. Regarding short-term risk, NHIV is similarly volatile compared to BREZ. This indicates similar risk in terms of short-term price fluctuations for NHIV.Check BREZ's competition here
InterPrivate Investment Partners V, Inc. Units (NASDAQ: IPVVU)
NHIV vs IPVVU Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, IPVVU has a market cap of 198.8M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while IPVVU trades at $9.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas IPVVU's P/E ratio is N/A. In terms of profitability, NHIV's ROE is N/A, compared to IPVVU's ROE of N/A. Regarding short-term risk, NHIV is less volatile compared to IPVVU. This indicates lower risk in terms of short-term price fluctuations for NHIV.Check IPVVU's competition here
Oceanhawk Acquisition Corp. Rights (NASDAQ: OHACR)
NHIV vs OHACR Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, OHACR has a market cap of 189.9M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while OHACR trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas OHACR's P/E ratio is N/A. In terms of profitability, NHIV's ROE is N/A, compared to OHACR's ROE of N/A. Regarding short-term risk, NHIV is less volatile compared to OHACR. This indicates lower risk in terms of short-term price fluctuations for NHIV.Check OHACR's competition here
Oceanhawk Acquisition Corp. Class A Ordinary Shares (NASDAQ: OHAC)
NHIV vs OHAC Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, OHAC has a market cap of 189.7M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while OHAC trades at $10.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas OHAC's P/E ratio is N/A. In terms of profitability, NHIV's ROE is N/A, compared to OHAC's ROE of N/A. Regarding short-term risk, NHIV is similarly volatile compared to OHAC. This indicates similar risk in terms of short-term price fluctuations for NHIV.Check OHAC's competition here
JAB Acquisition Corp. I Class A (NASDAQ: ATLQ)
NHIV vs ATLQ Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, ATLQ has a market cap of 187.4M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while ATLQ trades at $10.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas ATLQ's P/E ratio is N/A. In terms of profitability, NHIV's ROE is N/A, compared to ATLQ's ROE of N/A. Regarding short-term risk, NHIV is less volatile compared to ATLQ. This indicates lower risk in terms of short-term price fluctuations for NHIV.Check ATLQ's competition here
Dynamix Corporation (NASDAQ: ETHM)
NHIV vs ETHM Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, ETHM has a market cap of 182.1M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while ETHM trades at $10.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas ETHM's P/E ratio is -62.83. In terms of profitability, NHIV's ROE is N/A, compared to ETHM's ROE of +0.62%. Regarding short-term risk, NHIV is less volatile compared to ETHM. This indicates lower risk in terms of short-term price fluctuations for NHIV.Check ETHM's competition here
Roman DBDR Acquisition Corp. II (NASDAQ: DRDBW)
NHIV vs DRDBW Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, DRDBW has a market cap of 179.9M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while DRDBW trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas DRDBW's P/E ratio is 0.40. In terms of profitability, NHIV's ROE is N/A, compared to DRDBW's ROE of +0.02%. Regarding short-term risk, NHIV is less volatile compared to DRDBW. This indicates lower risk in terms of short-term price fluctuations for NHIV.Check DRDBW's competition here
JAB Acquisition Corp. I Units Cons of 1 Sh -A- + 1 Red Wt + 1 Rt (NASDAQ: ATLQU)
NHIV vs ATLQU Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, ATLQU has a market cap of 177.6M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while ATLQU trades at $10.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas ATLQU's P/E ratio is N/A. In terms of profitability, NHIV's ROE is N/A, compared to ATLQU's ROE of N/A. Regarding short-term risk, NHIV is less volatile compared to ATLQU. This indicates lower risk in terms of short-term price fluctuations for NHIV.Check ATLQU's competition here
Bluerock Acquisition Corp. (NASDAQ: BLRKU)
NHIV vs BLRKU Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, BLRKU has a market cap of 175.1M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while BLRKU trades at $10.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas BLRKU's P/E ratio is N/A. In terms of profitability, NHIV's ROE is N/A, compared to BLRKU's ROE of N/A. Regarding short-term risk, NHIV is similarly volatile compared to BLRKU. This indicates similar risk in terms of short-term price fluctuations for NHIV.Check BLRKU's competition here
Viking Acquisition Corp. I (NYSE: VACI-UN)
NHIV vs VACI-UN Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, VACI-UN has a market cap of 174.8M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while VACI-UN trades at $7.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas VACI-UN's P/E ratio is 85.59. In terms of profitability, NHIV's ROE is N/A, compared to VACI-UN's ROE of +0.01%. Regarding short-term risk, NHIV is similarly volatile compared to VACI-UN. This indicates similar risk in terms of short-term price fluctuations for NHIV.Check VACI-UN's competition here
Jab Acquisition Corp. I (NASDAQ: JAB)
NHIV vs JAB Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, JAB has a market cap of 174.2M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while JAB trades at $9.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas JAB's P/E ratio is N/A. In terms of profitability, NHIV's ROE is N/A, compared to JAB's ROE of N/A. Regarding short-term risk, NHIV is less volatile compared to JAB. This indicates lower risk in terms of short-term price fluctuations for NHIV.Check JAB's competition here
Long Table Growth Corp. Units (NASDAQ: LTGRU)
NHIV vs LTGRU Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, LTGRU has a market cap of 173.5M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while LTGRU trades at $10.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas LTGRU's P/E ratio is N/A. In terms of profitability, NHIV's ROE is N/A, compared to LTGRU's ROE of N/A. Regarding short-term risk, NHIV is less volatile compared to LTGRU. This indicates lower risk in terms of short-term price fluctuations for NHIV.Check LTGRU's competition here
Long Table Growth Corp. (NASDAQ: LTGR)
NHIV vs LTGR Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, LTGR has a market cap of 172.2M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while LTGR trades at $9.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas LTGR's P/E ratio is N/A. In terms of profitability, NHIV's ROE is N/A, compared to LTGR's ROE of N/A. Regarding short-term risk, NHIV is similarly volatile compared to LTGR. This indicates similar risk in terms of short-term price fluctuations for NHIV.Check LTGR's competition here
Texas Ventures Acquisition IV Corp. (NASDAQ: TVIV)
NHIV vs TVIV Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, TVIV has a market cap of 171.6M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while TVIV trades at $9.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas TVIV's P/E ratio is -5852.94. In terms of profitability, NHIV's ROE is N/A, compared to TVIV's ROE of N/A. Regarding short-term risk, NHIV is similarly volatile compared to TVIV. This indicates similar risk in terms of short-term price fluctuations for NHIV.Check TVIV's competition here
Collective Acquisition Corp. (NASDAQ: CCAQU)
NHIV vs CCAQU Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, CCAQU has a market cap of 159.4M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while CCAQU trades at $11.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas CCAQU's P/E ratio is 60.47. In terms of profitability, NHIV's ROE is N/A, compared to CCAQU's ROE of +0.03%. Regarding short-term risk, NHIV is similarly volatile compared to CCAQU. This indicates similar risk in terms of short-term price fluctuations for NHIV.Check CCAQU's competition here
Meridian3 Industrials Aquisition Corp Warrant (NASDAQ: MIACW)
NHIV vs MIACW Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, MIACW has a market cap of 159.4M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while MIACW trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas MIACW's P/E ratio is N/A. In terms of profitability, NHIV's ROE is N/A, compared to MIACW's ROE of N/A. Regarding short-term risk, NHIV is less volatile compared to MIACW. This indicates lower risk in terms of short-term price fluctuations for NHIV.Check MIACW's competition here
Arc Group Securities Acquisition I (NASDAQ: FJDIU)
NHIV vs FJDIU Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, FJDIU has a market cap of 157.2M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while FJDIU trades at $10.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas FJDIU's P/E ratio is N/A. In terms of profitability, NHIV's ROE is N/A, compared to FJDIU's ROE of N/A. Regarding short-term risk, NHIV is similarly volatile compared to FJDIU. This indicates similar risk in terms of short-term price fluctuations for NHIV.Check FJDIU's competition here
Ocean Capital Acquisition Corporation (NYSE: OCAC)
NHIV vs OCAC Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, OCAC has a market cap of 156.7M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while OCAC trades at $10.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas OCAC's P/E ratio is -692.05. In terms of profitability, NHIV's ROE is N/A, compared to OCAC's ROE of N/A. Regarding short-term risk, NHIV is similarly volatile compared to OCAC. This indicates similar risk in terms of short-term price fluctuations for NHIV.Check OCAC's competition here
Collective Acquisition Corp. (NASDAQ: CCAQ)
NHIV vs CCAQ Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, CCAQ has a market cap of 156.1M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while CCAQ trades at $10.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas CCAQ's P/E ratio is 58.78. In terms of profitability, NHIV's ROE is N/A, compared to CCAQ's ROE of +0.03%. Regarding short-term risk, NHIV is less volatile compared to CCAQ. This indicates lower risk in terms of short-term price fluctuations for NHIV.Check CCAQ's competition here
Graf Global Corp. (AMEX: TONT)
NHIV vs TONT Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, TONT has a market cap of 155.3M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while TONT trades at $10.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas TONT's P/E ratio is 61.46. In terms of profitability, NHIV's ROE is N/A, compared to TONT's ROE of N/A. Regarding short-term risk, NHIV is less volatile compared to TONT. This indicates lower risk in terms of short-term price fluctuations for NHIV.Check TONT's competition here
BRC Group Holdings Inc. 5% Sr. Notes due 2026 (NASDAQ: RILYG)
NHIV vs RILYG Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, RILYG has a market cap of 154.4M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while RILYG trades at $24.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas RILYG's P/E ratio is 4.66. In terms of profitability, NHIV's ROE is N/A, compared to RILYG's ROE of +94.15%. Regarding short-term risk, NHIV is less volatile compared to RILYG. This indicates lower risk in terms of short-term price fluctuations for NHIV.Check RILYG's competition here
Social Capital Hedosophia Holdings Corp. IV (NASDAQ: IPOD)
NHIV vs IPOD Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, IPOD has a market cap of 154.4M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while IPOD trades at $10.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas IPOD's P/E ratio is 58.12. In terms of profitability, NHIV's ROE is N/A, compared to IPOD's ROE of +0.05%. Regarding short-term risk, NHIV is less volatile compared to IPOD. This indicates lower risk in terms of short-term price fluctuations for NHIV.Check IPOD's competition here
BRC Group Holdings Inc. 5.25% Sr. Notes due 2028 (NASDAQ: RILYZ)
NHIV vs RILYZ Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, RILYZ has a market cap of 153.3M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while RILYZ trades at $16.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas RILYZ's P/E ratio is 3.11. In terms of profitability, NHIV's ROE is N/A, compared to RILYZ's ROE of +94.15%. Regarding short-term risk, NHIV is less volatile compared to RILYZ. This indicates lower risk in terms of short-term price fluctuations for NHIV.Check RILYZ's competition here
Black Spade Acquisition II Co (NASDAQ: BSIIU)
NHIV vs BSIIU Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, BSIIU has a market cap of 152.8M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while BSIIU trades at $9.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas BSIIU's P/E ratio is N/A. In terms of profitability, NHIV's ROE is N/A, compared to BSIIU's ROE of -266.79%. Regarding short-term risk, NHIV is similarly volatile compared to BSIIU. This indicates similar risk in terms of short-term price fluctuations for NHIV.Check BSIIU's competition here
JAB Acquisition Corp I (NASDAQ: JABRU)
NHIV vs JABRU Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, JABRU has a market cap of 152.3M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while JABRU trades at $10.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas JABRU's P/E ratio is N/A. In terms of profitability, NHIV's ROE is N/A, compared to JABRU's ROE of N/A. Regarding short-term risk, NHIV is similarly volatile compared to JABRU. This indicates similar risk in terms of short-term price fluctuations for NHIV.Check JABRU's competition here
B. Riley Financial, Inc. 6.00% Senior Notes Due 2028 (NASDAQ: RILYT)
NHIV vs RILYT Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, RILYT has a market cap of 152.2M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while RILYT trades at $18.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas RILYT's P/E ratio is 3.53. In terms of profitability, NHIV's ROE is N/A, compared to RILYT's ROE of +94.15%. Regarding short-term risk, NHIV is less volatile compared to RILYT. This indicates lower risk in terms of short-term price fluctuations for NHIV.Check RILYT's competition here
SPACCircle Acquisition Corp. (NASDAQ: SCQCU)
NHIV vs SCQCU Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, SCQCU has a market cap of 150.3M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while SCQCU trades at $10.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas SCQCU's P/E ratio is N/A. In terms of profitability, NHIV's ROE is N/A, compared to SCQCU's ROE of N/A. Regarding short-term risk, NHIV is less volatile compared to SCQCU. This indicates lower risk in terms of short-term price fluctuations for NHIV.Check SCQCU's competition here
Forefront Tech Holdings Acquisition Corp Unit (NASDAQ: FTHAU)
NHIV vs FTHAU Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, FTHAU has a market cap of 148.5M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while FTHAU trades at $11.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas FTHAU's P/E ratio is N/A. In terms of profitability, NHIV's ROE is N/A, compared to FTHAU's ROE of N/A. Regarding short-term risk, NHIV is similarly volatile compared to FTHAU. This indicates similar risk in terms of short-term price fluctuations for NHIV.Check FTHAU's competition here
BRC Group Holdings, Inc. (NASDAQ: RILY)
NHIV vs RILY Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, RILY has a market cap of 147.1M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while RILY trades at $3.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas RILY's P/E ratio is 0.29. In terms of profitability, NHIV's ROE is N/A, compared to RILY's ROE of +94.15%. Regarding short-term risk, NHIV is less volatile compared to RILY. This indicates lower risk in terms of short-term price fluctuations for NHIV.Check RILY's competition here
Southern Cross Acquisition I Corp. (NASDAQ: NCO)
NHIV vs NCO Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, NCO has a market cap of 146.9M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while NCO trades at $9.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas NCO's P/E ratio is N/A. In terms of profitability, NHIV's ROE is N/A, compared to NCO's ROE of N/A. Regarding short-term risk, NHIV is similarly volatile compared to NCO. This indicates similar risk in terms of short-term price fluctuations for NHIV.Check NCO's competition here
BRC Group Holdings, Inc. - Depositary Shares, each representing a 1/1000th fractional interest in a share of Series B Cumulative Perpetual Preferred Stock (NASDAQ: RILYL)
NHIV vs RILYL Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, RILYL has a market cap of 146.7M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while RILYL trades at $6.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas RILYL's P/E ratio is 0.46. In terms of profitability, NHIV's ROE is N/A, compared to RILYL's ROE of +94.15%. Regarding short-term risk, NHIV is less volatile compared to RILYL. This indicates lower risk in terms of short-term price fluctuations for NHIV.Check RILYL's competition here
BRC Group Holdings, Inc. (NASDAQ: RILYP)
NHIV vs RILYP Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, RILYP has a market cap of 140.2M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while RILYP trades at $6.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas RILYP's P/E ratio is 0.43. In terms of profitability, NHIV's ROE is N/A, compared to RILYP's ROE of +94.15%. Regarding short-term risk, NHIV is less volatile compared to RILYP. This indicates lower risk in terms of short-term price fluctuations for NHIV.Check RILYP's competition here
Social Commerce Partners Corporation (NASDAQ: SCPQW)
NHIV vs SCPQW Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, SCPQW has a market cap of 138.5M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while SCPQW trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas SCPQW's P/E ratio is 4.92. In terms of profitability, NHIV's ROE is N/A, compared to SCPQW's ROE of +0.02%. Regarding short-term risk, NHIV is less volatile compared to SCPQW. This indicates lower risk in terms of short-term price fluctuations for NHIV.Check SCPQW's competition here
Breeze Acquisition Corp. II (NASDAQ: BREZR)
NHIV vs BREZR Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, BREZR has a market cap of 130.6M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while BREZR trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas BREZR's P/E ratio is 40.16. In terms of profitability, NHIV's ROE is N/A, compared to BREZR's ROE of +0.53%. Regarding short-term risk, NHIV is less volatile compared to BREZR. This indicates lower risk in terms of short-term price fluctuations for NHIV.Check BREZR's competition here
East West Ave Acquisition Corp. Common Stock (NASDAQ: EWAV)
NHIV vs EWAV Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, EWAV has a market cap of 127.7M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while EWAV trades at $9.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas EWAV's P/E ratio is -14200.00. In terms of profitability, NHIV's ROE is N/A, compared to EWAV's ROE of N/A. Regarding short-term risk, NHIV is less volatile compared to EWAV. This indicates lower risk in terms of short-term price fluctuations for NHIV.Check EWAV's competition here
Southern Cross Acquisition I Corp. (NASDAQ: NCOOU)
NHIV vs NCOOU Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, NCOOU has a market cap of 119M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while NCOOU trades at $10.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas NCOOU's P/E ratio is N/A. In terms of profitability, NHIV's ROE is N/A, compared to NCOOU's ROE of N/A. Regarding short-term risk, NHIV is similarly volatile compared to NCOOU. This indicates similar risk in terms of short-term price fluctuations for NHIV.Check NCOOU's competition here
Plutonian Acquisition Corp II (NYSE: PLUN)
NHIV vs PLUN Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, PLUN has a market cap of 115.3M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while PLUN trades at $10.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas PLUN's P/E ratio is 337.67. In terms of profitability, NHIV's ROE is N/A, compared to PLUN's ROE of N/A. Regarding short-term risk, NHIV is less volatile compared to PLUN. This indicates lower risk in terms of short-term price fluctuations for NHIV.Check PLUN's competition here
Shepherd Ave Capital Acquisition Corporation (NASDAQ: SPHA)
NHIV vs SPHA Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, SPHA has a market cap of 111.7M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while SPHA trades at $10.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas SPHA's P/E ratio is N/A. In terms of profitability, NHIV's ROE is N/A, compared to SPHA's ROE of -1.30%. Regarding short-term risk, NHIV is less volatile compared to SPHA. This indicates lower risk in terms of short-term price fluctuations for NHIV.Check SPHA's competition here
Arc Group Securities Acquisition I (NASDAQ: FJDI)
NHIV vs FJDI Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, FJDI has a market cap of 110.4M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while FJDI trades at $9.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas FJDI's P/E ratio is N/A. In terms of profitability, NHIV's ROE is N/A, compared to FJDI's ROE of N/A. Regarding short-term risk, NHIV is less volatile compared to FJDI. This indicates lower risk in terms of short-term price fluctuations for NHIV.Check FJDI's competition here
Enhanced Group Inc. Class A (NYSE: ENHA)
NHIV vs ENHA Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, ENHA has a market cap of 106.2M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while ENHA trades at $7.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas ENHA's P/E ratio is -28.74. In terms of profitability, NHIV's ROE is N/A, compared to ENHA's ROE of -3.98%. Regarding short-term risk, NHIV is less volatile compared to ENHA. This indicates lower risk in terms of short-term price fluctuations for NHIV.Check ENHA's competition here
Amanat Acquisition Corp Class A Ordinary Shares (NASDAQ: AMAN)
NHIV vs AMAN Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, AMAN has a market cap of 97.9M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while AMAN trades at $10.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas AMAN's P/E ratio is N/A. In terms of profitability, NHIV's ROE is N/A, compared to AMAN's ROE of N/A. Regarding short-term risk, NHIV is less volatile compared to AMAN. This indicates lower risk in terms of short-term price fluctuations for NHIV.Check AMAN's competition here
Cayson Acquisition Corp (NASDAQ: CAPNU)
NHIV vs CAPNU Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, CAPNU has a market cap of 94M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while CAPNU trades at $11.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas CAPNU's P/E ratio is 56.23. In terms of profitability, NHIV's ROE is N/A, compared to CAPNU's ROE of +0.03%. Regarding short-term risk, NHIV is similarly volatile compared to CAPNU. This indicates similar risk in terms of short-term price fluctuations for NHIV.Check CAPNU's competition here
FTAC Emerald Acquisition Corp. (NASDAQ: FLDD)
NHIV vs FLDD Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, FLDD has a market cap of 85.6M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while FLDD trades at $6.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas FLDD's P/E ratio is -75.13. In terms of profitability, NHIV's ROE is N/A, compared to FLDD's ROE of N/A. Regarding short-term risk, NHIV is less volatile compared to FLDD. This indicates lower risk in terms of short-term price fluctuations for NHIV.Check FLDD's competition here
Research Alliance Corp. Iv (NASDAQ: RACD)
NHIV vs RACD Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, RACD has a market cap of 81.1M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while RACD trades at $10.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas RACD's P/E ratio is N/A. In terms of profitability, NHIV's ROE is N/A, compared to RACD's ROE of N/A. Regarding short-term risk, NHIV is less volatile compared to RACD. This indicates lower risk in terms of short-term price fluctuations for NHIV.Check RACD's competition here
Armada Acquisition Corp. III (NASDAQ: AACIU)
NHIV vs AACIU Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, AACIU has a market cap of 75.3M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while AACIU trades at $10.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas AACIU's P/E ratio is N/A. In terms of profitability, NHIV's ROE is N/A, compared to AACIU's ROE of -0.24%. Regarding short-term risk, NHIV is less volatile compared to AACIU. This indicates lower risk in terms of short-term price fluctuations for NHIV.Check AACIU's competition here
Collective Acquisition Corp. (NASDAQ: CCAQW)
NHIV vs CCAQW Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, CCAQW has a market cap of 66.7M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while CCAQW trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas CCAQW's P/E ratio is 0.66. In terms of profitability, NHIV's ROE is N/A, compared to CCAQW's ROE of +0.03%. Regarding short-term risk, NHIV is less volatile compared to CCAQW. This indicates lower risk in terms of short-term price fluctuations for NHIV.Check CCAQW's competition here
Bayview Acquisition Corp Unit (NASDAQ: BAYAU)
NHIV vs BAYAU Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, BAYAU has a market cap of 63.1M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while BAYAU trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas BAYAU's P/E ratio is 258.06. In terms of profitability, NHIV's ROE is N/A, compared to BAYAU's ROE of -0.03%. Regarding short-term risk, NHIV is less volatile compared to BAYAU. This indicates lower risk in terms of short-term price fluctuations for NHIV.Check BAYAU's competition here
Blueport Acquisition Ltd (NASDAQ: BPACU)
NHIV vs BPACU Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, BPACU has a market cap of 61.3M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while BPACU trades at $10.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas BPACU's P/E ratio is N/A. In terms of profitability, NHIV's ROE is N/A, compared to BPACU's ROE of +0.01%. Regarding short-term risk, NHIV is similarly volatile compared to BPACU. This indicates similar risk in terms of short-term price fluctuations for NHIV.Check BPACU's competition here
Blueport Acquisition Ltd (NASDAQ: BPAC)
NHIV vs BPAC Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, BPAC has a market cap of 61.2M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while BPAC trades at $10.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas BPAC's P/E ratio is N/A. In terms of profitability, NHIV's ROE is N/A, compared to BPAC's ROE of +0.01%. Regarding short-term risk, NHIV is less volatile compared to BPAC. This indicates lower risk in terms of short-term price fluctuations for NHIV.Check BPAC's competition here
Cartesian Growth Corporation III (NASDAQ: CGCTW)
NHIV vs CGCTW Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, CGCTW has a market cap of 50.4M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while CGCTW trades at $1.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas CGCTW's P/E ratio is N/A. In terms of profitability, NHIV's ROE is N/A, compared to CGCTW's ROE of -0.15%. Regarding short-term risk, NHIV is less volatile compared to CGCTW. This indicates lower risk in terms of short-term price fluctuations for NHIV.Check CGCTW's competition here
Horizon Quantum Holdings Ltd. Warrant (NASDAQ: HQWWW)
NHIV vs HQWWW Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, HQWWW has a market cap of 50.3M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while HQWWW trades at $6.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas HQWWW's P/E ratio is -1.56. In terms of profitability, NHIV's ROE is N/A, compared to HQWWW's ROE of -2.97%. Regarding short-term risk, NHIV is less volatile compared to HQWWW. This indicates lower risk in terms of short-term price fluctuations for NHIV.Check HQWWW's competition here
YHN Acquisition I Limited (NASDAQ: YHNA)
NHIV vs YHNA Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, YHNA has a market cap of 47.7M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while YHNA trades at $11.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas YHNA's P/E ratio is 85.54. In terms of profitability, NHIV's ROE is N/A, compared to YHNA's ROE of +0.10%. Regarding short-term risk, NHIV is less volatile compared to YHNA. This indicates lower risk in terms of short-term price fluctuations for NHIV.Check YHNA's competition here
YHN Acquisition I Limited Unit (NASDAQ: YHNAU)
NHIV vs YHNAU Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, YHNAU has a market cap of 47.7M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while YHNAU trades at $11.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas YHNAU's P/E ratio is 551.74. In terms of profitability, NHIV's ROE is N/A, compared to YHNAU's ROE of +0.10%. Regarding short-term risk, NHIV is less volatile compared to YHNAU. This indicates lower risk in terms of short-term price fluctuations for NHIV.Check YHNAU's competition here
Horizon Space Acquisition II Corp. (NASDAQ: HSPT)
NHIV vs HSPT Comparison November 2026
NewHold Investment Corp IV Class A Ordinary Shares (NASDAQ: NHIV) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIV stands at 273.5M. In comparison, HSPT has a market cap of 46.4M. Regarding current trading prices, NHIV is priced at $9.94 on the NASDAQ, while HSPT trades at $5.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIV currently has a P/E ratio of N/A, whereas HSPT's P/E ratio is 41.86. In terms of profitability, NHIV's ROE is N/A, compared to HSPT's ROE of +0.04%. Regarding short-term risk, NHIV is less volatile compared to HSPT. This indicates lower risk in terms of short-term price fluctuations for NHIV.Check HSPT's competition here